Two New Treatments for Gonorrhea; one is available now!

Two New Treatments for Gonorrhea; one is available now!

In this episode of the Conversations with CEI, infectious disease specialist Dr. Steven Fine delves into groundbreaking advancements in the treatment of urogenital gonorrhea. The episode highlights the FDA's December 2025 approval of two innovative oral therapies that mark a significant step forward in combating this prevalent sexually transmitted infection.

Dr. Fine discusses the first of these treatments, Zoliflodacin (Nuzolvence), a novel medication specifically developed for urogenital gonorrhea. Administered as a single oral dose, it offers patients a convenient and effective option. The second treatment, Gepotidacin (Blujepa), is a versatile drug initially approved in March 2025 for urinary tract infections (UTIs). Now, it has been authorized for urogenital gonorrhea treatment, requiring two oral doses for optimal efficacy.

Throughout the episode, Dr. Fine provides insights into the clinical trials, mechanisms of action, and potential impact of these therapies on public health. He also emphasizes the importance of addressing antibiotic resistance in gonorrhea and how these new treatments may help mitigate this growing concern.

For more information, listeners can refer to the FDA's official announcement and other resources provided below.

Tune in to this episode to learn more about these exciting developments and their implications for the future of infectious disease treatment. Related Content:

Episoder(60)

Compassionate Care for LGBTQ+ Individuals Struggling with Substance Use Disorder

Compassionate Care for LGBTQ+ Individuals Struggling with Substance Use Disorder

Research suggests that LGBTQ adults have higher rates of substance use and mental health issues, compared to their heterosexual cisgender peers.  These health disparities are often related to minority...

12 Des 202428min

Reflections from the 2024 CDC STI Prevention Conference

Reflections from the 2024 CDC STI Prevention Conference

For the first time since 2018 and since the COVID-19 pandemic, the Centers for Disease Control and Prevention hosted their biennial STI Prevention Conference in-person in Atlanta, GA from September 16...

7 Nov 202422min

The Case for Chronic Pain Management among People Who Use Opioids

The Case for Chronic Pain Management among People Who Use Opioids

Are current guidelines failing chronic pain patients with a history of substance-use disorders? Find out why Dr. Wang and Dr. Kelly are calling for urgent policy changes and how updated guidelines can...

10 Okt 202446min

An Exciting New Twice-yearly Option for HIV PrEP

An Exciting New Twice-yearly Option for HIV PrEP

“This podcast discusses the recent presentation of data for lenacapavir, a potent capsid inhibitor for HIV that was 100% effective in preventing HIV infection in cis-gender woman at risk for HIV. If a...

10 Sep 202413min

When HIV Tests Perplex: Expert Insights on Ambiguous and Discordant Results

When HIV Tests Perplex: Expert Insights on Ambiguous and Discordant Results

Providers calling into our CEI hotline often ask me what to do when their patient's HIV test results are unclear. These ambiguous or discordant test results can be a source of anxiety and confusion fo...

8 Aug 202429min

It’s Complicated…but Necessary! Navigating Confidential Sexual Healthcare for Adolescents

It’s Complicated…but Necessary! Navigating Confidential Sexual Healthcare for Adolescents

“Nobody goes into adolescent medicine or into a field of medicine that serves adolescent patients because it’s simple and straightforward, right?” In May 2024, the New York State Department of Health ...

11 Jul 202422min

Special Conversations with CEI: Best Practices for Hepatitis C and Pregnancy Screening: Advice from a Fellow Clinician

Special Conversations with CEI: Best Practices for Hepatitis C and Pregnancy Screening: Advice from a Fellow Clinician

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

13 Jun 202434min

Special Conversations with CEI: Best Practices for Working with People Who Use Substances

Special Conversations with CEI: Best Practices for Working with People Who Use Substances

Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly 10-fold over the past 20 years and approxi...

6 Jun 202430min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
rss-strid-de-norske-borgerkrigene
treningspodden
jakt-og-fiskepodden
rss-sunn-okonomi
sinnsyn
mikkels-paskenotter
takk-og-lov-med-anine-kierulf
hverdagspsyken
gravid-uke-for-uke
rss-kunsten-a-leve
tomprat-med-gunnar-tjomlid
hagespiren-podcast
rss-bisarr-historie
rss-var-forste-kaffe
fryktlos
rss-kull